(0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

Crystal Gateway Marriott

2026年9月23日 (水) 午前 7:00 - 2026年9月25日 (金) 午後 3:00

1700 Richmond Highway, Arlington, VA 22202, USA

Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

参加申し込み
Early Bird Ends

DAYS

HOURS

MINUTES

SECONDS

ハイライト＆特長

Need Approval in Order to Attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.

What is happening at FDA/DIA Oligonucleotide-Based Therapeutics Conference

  • Learn about the latest advancements, regulatory updates, and emerging trends in oligonucleotide therapies directly from leading industry experts and global regulators
  • Our three tracks (Clinical, Nonclinical, and CMC) will comprehensively cover a wide range of aspects of oligonucleotide therapeutics—from development to regulatory collaboration—and provide practical insights into current challenges and successful strategies for overcoming hurdles in clinical use, safety assessments, and CMC
  • This conference offers a networking opportunity to engage with peers, innovators, and regulators in sessions designed to foster meaningful collaboration and knowledge exchange


参加申し込み

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。